Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

3 Screen Electronic Alert

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00550082
Recruitment Status : Completed
First Posted : October 26, 2007
Last Update Posted : February 10, 2012
Sponsor:
Collaborator:
Eisai Inc.
Information provided by (Responsible Party):
Samuel Z.Goldhaber, MD, Brigham and Women's Hospital

Brief Summary:
Evaluation of physician responses to BICS-Clinical Information 3-screen alerts that informs the clinician that his/her patient may be eligible for thromboprophylaxis.

Condition or disease
Deep Vein Thrombosis Pulmonary Embolism Cancer

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 880 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Multi-Screen Electronic Alert for Venous Thromboembolism Prevention
Study Start Date : July 2007
Actual Primary Completion Date : November 2009
Actual Study Completion Date : November 2009



Primary Outcome Measures :
  1. Venous Thromboembolism and Bleeding Events [ Time Frame: 90 Days ]

Secondary Outcome Measures :
  1. Re-hospitalization [ Time Frame: 90 Days ]
  2. Mortality [ Time Frame: 30 Days ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Hospitalized patients at Brigham and Women's Hospital from medical and surgical services who are 18 yrs old or older and are at a moderate to high risk for venous thromboembolism (VTE)
Criteria

Inclusion Criteria:

  • Hospitalized patients at Brigham and Women's Hospital from medical and surgical services who are 18 yrs old or older and are at a moderate to high risk for venous thromboembolism (VTE)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00550082


Locations
Layout table for location information
United States, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
Brigham and Women's Hospital
Eisai Inc.
Investigators
Layout table for investigator information
Principal Investigator: Samuel Z Goldhaber, MD Brigham and Women's Hospital

Additional Information:
Publications:

Layout table for additonal information
Responsible Party: Samuel Z.Goldhaber, MD, Director, VTE Research Group, Brigham and Women's Hospital
ClinicalTrials.gov Identifier: NCT00550082    
Other Study ID Numbers: 2006-P-002346
First Posted: October 26, 2007    Key Record Dates
Last Update Posted: February 10, 2012
Last Verified: February 2012
Keywords provided by Samuel Z.Goldhaber, MD, Brigham and Women's Hospital:
Anticoagulation
High-Risk
Deep Vein Thrombosis
Pulmonary Embolism
Surgery
Additional relevant MeSH terms:
Layout table for MeSH terms
Pulmonary Embolism
Thrombosis
Embolism
Venous Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases